A robust growth trajectory is underway in the global intravenous iron drugs market, with projections estimating its value to surge from USD 2.8 billion in 2022 to USD 6.3 billion by 2032. This impressive growth reflects a compound annual growth rate (CAGR) of 8.5% over the forecast period, driven by the increasing incidence of chronic …
Tag Archives: Intravenous Iron Drugs Market
Intravenous Iron Drugs Market is expected to reach US$ 6.3 Billion by 2032, At a compound annual growth rate of 8.5% | FMI
The Intravenous Iron Drugs Market is projected to surge in the coming years, according to a recent market survey by FMI. The market, valued at US$2.6 billion in 2021, is expected to reach a staggering US$6.3 billion by 2032, reflecting a significant increase. This growth is largely driven by the rising demand for ferric carboxymaltose, …
Intravenous Iron Drugs Market Embarks on a Remarkable Journey Towards a US$ 6.3 Billion Milestone by 2032
The worldwide intravenous iron medication market sales is expected to increase from US$ 2.6 billion in 2021 to US$ 6.3 billion by 2032. The report’s findings suggest that intravenous iron medications will be in great demand since ferric carboxymaltose would provide the lion’s share of revenue. The American Heart Association predicts that by 2035, more …
Ferric Carboxymaltose in High Demand | Leading the Intravenous Iron Drugs Market Revenue
According to a recent market assessment conducted by Future Market Insights, the global Intravenous Iron Drugs Market Size is predicted to reach US$ 6.3 billion by 2032. According to the report’s findings, Intravenous Iron Drugs revenue created by Ferric Carboxymaltose will be in high demand in the market, as they will generate the majority of …